Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Phase II Study of MEDI-507, Administered by Injection to Adults With Psoriasis

ClinicalTrials.gov ID: NCT00540618

Public ClinicalTrials.gov record NCT00540618. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 4, 2026, 9:53 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Randomized, Placebo-Controlled, Double-Blind Study of MEDI-507, A Humanized Monoclonal Antibody That Binds to the CD2 Receptor, Administered by Subcutaneous Injection to Adults With Plaque Psoriasis.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

To compare disease activity, as measured by PASI score, of three MEDI-507 dosing (injection)regimens vs. placebo.

Study identification

NCT ID
NCT00540618
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
MedImmune LLC
Industry
Enrollment
420 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 31, 2001
Primary completion
Not listed
Completion
Jun 30, 2003
Last update posted
Nov 27, 2007

2001 – 2003

United States locations

U.S. sites
36
U.S. states
20
U.S. cities
32
Facility City State ZIP Site status
MDS Pharma Services (US) Inc. Phoenix Arizona 85040
Bressinck-Parker-Dinehart-Sangster Dermatology, PA Little Rock Arkansas 72205
Associates in Research, Inc. Fresno California 93710
nTouch Research Corporation San Diego California 92103
Solano Clinical Research Vallejo California 94589
Dermatology Specialists, Inc. Vista California 92083
Colorado Medical Research Center, Inc. Denver Colorado 80210
Cherry Creek Dermatology Denver Colorado 80246
The Savin Center, PC New Haven Connecticut 06511
North Florida Dermatology Associates, PA Jacksonville Florida 32204
ICSL-Clinical Studies Sarasota Florida 34232
Comprehensive Research Institute Tampa Florida 33607
Atlanta Dermatology, Vein & Research Center, LLC Alpharetta Georgia 30005
Northwestern University Medical School Chicago Illinois 60611-2923
Research Solutions, LLC Evansville Indiana 47714
The South Bend Clinic South Bend Indiana 46617
Massachusetts General Hospital Boston Massachusetts 02114
FutureCare Studies Springfield Massachusetts 01107
Washington University School of Medicine St Louis Missouri 63110
University of Medicine & Dentistry of New Jersey Robert Wood Johnson Medical School and Clinical Research Center New Brunswick New Jersey 08903-0019
Probe Inc. Riverside Park New Jersey 08075
Associates in Dermatology Research Rutherford New Jersey 07070
Sadick Research Group New York New York 10021
Mount Sinai School of Medicine New York New York 10029
Wake Forest University School of Medicine Winston-Salem North Carolina 27157
University Dermatology Consultants, Inc. Cincinnatti Ohio 45219
Oregon Medical Research Center, PC Portland Oregon 97223
Northeast Clinical Research Center Allentown Pennsylvania 18104
Paddington Testing Company Philadelphia Pennsylvania 19103
Radiant Research Philadelphia Pennsylvania 19115
Clinicalm Partners-LLC Johnston Rhode Island 02919
Harmony Clinical Research, Inc. Johnson City Tennessee 37601
Dermatology Consultants, PC Nashville Tennessee 37205
Veteran's Administration Medical Center Nashville Tennessee 37212-2637
Breco Research, Ltd. Houston Texas 77024
Dermatology Clinical Research Center of San Antonio San Antonio Texas 78229

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00540618, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 27, 2007 · Synced Sep 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00540618 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →